Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) – Investment analysts at Cormark cut their FY2016 earnings per share estimates for Cipher Pharmaceuticals in a research report issued on Monday. Cormark analyst D. Novak now expects that the firm will post earnings of ($1.46) per share for the year, down from their previous estimate of ($0.51). Cormark also […]
